Untangling the complexity and impact of tau protein ubiquitination.

Fibrils Neurodegeneration Post-translational modifications Tau protein Ubiquitination

Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
18 Sep 2024
Historique:
revised: 16 09 2024
received: 30 06 2024
accepted: 16 09 2024
medline: 18 9 2024
pubmed: 18 9 2024
entrez: 18 9 2024
Statut: aheadofprint

Résumé

The microtubule-associated protein tau is an intrinsically disordered protein highly expressed in neuronal axons. In healthy neurons, tau regulates microtubule dynamics and neurite outgrowth. However, pathological conditions can trigger aberrant tau aggregation into insoluble filaments, a hallmark of neurodegenerative disorders known as tauopathies. Tau undergoes diverse posttranslational modifications (PTMs), suggesting complex regulation and potentially varied functions. Among PTMs, the role and mechanisms of ubiquitination in physiology and disease have remained enigmatic. The past three decades have witnessed the emergence of key studies on tau protein ubiquitination. In this concept, we discuss how these investigations have begun to shed light on the ubiquitination patterns of physiological and pathological tau, the responsible enzymatic machinery, and the influence of ubiquitination on tau aggregation. We also provide an overview of the semi-synthetic methods that have enabled in vitro investigations of conformational transitions of tau induced by ubiquitin modification. Finally, we discuss future perspectives in the field necessary to elucidate the molecular mechanisms of tau ubiquitination and clearance.

Identifiants

pubmed: 39291301
doi: 10.1002/cbic.202400566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400566

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Daniele Trivellato (D)

University of Verona, Department of Biotechnology, ITALY.

Francesca Munari (F)

University of Verona, Department of Biotechnology, ITALY.

Michael Assfalg (M)

University of Verona, Department of Biotechnology, ITALY.

Stefano Capaldi (S)

University of Verona, Department of Biotechnology, ITALY.

Mariapina D'Onofrio (M)

University of Verona, Department of Biotechnology, Strada le Grazie 15, 37134, Verona, ITALY.

Classifications MeSH